GLP-1 Provider Cost Comparison Chart (Verified April 2026)
By the Weight Loss Provider Guide research team — an independent comparison resource for GLP-1 telehealth providers.
· Next scheduled review: July 28, 2026
Affiliate disclosure: Some links on this page earn us a commission when you sign up through them. Our rankings, chart data, and editorial conclusions are based on fit, pricing transparency, and verification — not commission alone.
[Skip to the full comparison chart ↓]
Bottom line up front
The cheapest GLP-1 provider in our verified chart depends entirely on which “cheapest” you mean. The lowest 90-day total cash-pay cost is roughly $438–$473 (Yucca Health on a 6-month plan or Enhance MD’s Core monthly plan). The lowest FDA-approved 90-day cost is roughly $744–$784 through Sesame or Ro on the Wegovy® pill at the lowest dose. The lowest headline first-month price is $39 — Ro Body membership — but the medication is billed separately on top.
Every row in the chart below shows three numbers most competitors don’t combine: first-month price, refill price (months 2–3), and a calculated 90-day total. If a provider raises the price in month two, you see it. If a provider keeps the price flat, you see that too.
Best-fit verdict at a glance
| If your priority is… | Start with | Why this row |
|---|---|---|
| FDA-approved Wegovy® / Zepbound® / Foundayo™ / Ozempic® | Ro | Broadest brand-name menu, free GLP-1 Insurance Coverage Checker, insurance concierge handles prior authorization, matches LillyDirect® / NovoCare® / TrumpRx pricing |
| Deep cash-pay compounded menu (injection + tablet) | MEDVi | Compounded semaglutide and tirzepatide in both weekly injectable and daily oral tablet form, multiple licensed compounding pharmacy partners, LegitScript-certified |
| Same monthly price at every dose (compounded) | Eden | Flat-rate pricing — your refill price doesn’t change as your prescribed dose increases |
| No needles — oral, lozenge, or sublingual | SHED for compounded oral; Ro or Sesame for FDA-approved oral | SHED has the widest compounded oral menu (drops, lozenges, liposomal tablets); Ro and Sesame carry FDA-approved oral options including Wegovy® pill and Foundayo™ |
| Lab work and a more clinical-feel program | Enhance MD | Metabolic lab testing every 6 months included, flat pricing across all doses, three plan tiers (semaglutide, tirzepatide, combo) |
| Brand-name with a Costco discount | Sesame | Costco members get Wegovy® / Ozempic® at $349/month at Costco Pharmacy with a Sesame prescription (subject to change/location); broadest branded formulary including Saxenda® |
| Pay-over-time (Klarna / Affirm / Afterpay) | Yucca Health | One of the only telehealth GLP-1 providers offering BNPL on 6-month plans; lowest effective monthly at ~$146/month (compounded semaglutide) |
| Familiar consumer telehealth brand with FDA-approved meds | Hims (male-coded) or Hers (female-coded) | Following the March 2026 Novo Nordisk partnership, both carry Wegovy® pen, Wegovy® pill, Ozempic®, Zepbound®, Foundayo™, and Mounjaro®. Membership and medication billed separately. |
| Not sure which row fits you | Free 60-second matching quiz | We ask 6 questions about budget, insurance, format, and state and route you to the provider that fits |
Why most “cheap GLP-1” ads aren’t actually cheap (the one honest thing this page will admit)
We have to tell you something most affiliate sites won’t. The cheapest GLP-1 ad is almost never the cheapest GLP-1 plan. Several legitimate, well-known providers — including some we recommend on this page — advertise $39, $49, $99, $129, or $149 for the first month. The refill price in month two is sometimes the same. Sometimes it’s $199, $229, $249, $299, $349, or $399. Sometimes the headline number is the annual-prepay effective rate, meaning you’d need to pay six or twelve months in advance to lock it in. Sometimes the advertised price includes the membership. Sometimes it doesn’t. Occasionally a provider’s checkout page reveals a price different from the one on the landing page.
None of that is fraud. It’s standard intro pricing and tiered subscription billing in telehealth. But it makes a side-by-side price comparison genuinely confusing if all you see is “starting at $X.”
That’s why every row in the chart below shows three columns the others don’t combine: first-month price, refill price (months 2–3), and a calculated 90-day total. If a provider raises the price in month two, you see it. If a provider locks the price the whole way through, you see that too. This is what we owe you for clicking — not a ranking of who pays us best, but a chart that actually helps you decide.

Verify first-month price, refill price, and plan length before paying.
Not sure yet? Take our free 60-second matching quiz →
GLP-1 Provider Cost Comparison Chart
The chart below compares 14 telehealth GLP-1 providers across first-month price, refill price, calculated first-90-day total, what’s included, dose-pricing rules, FDA route (compounded versus FDA-approved), HSA/FSA acceptance, BNPL availability, and cancellation terms. Every cell was verified against the provider’s published pricing page on . Rows marked [NEEDS CHECKOUT VERIFICATION] indicate the provider’s public pages show conflicting pricing or hide the full price behind intake.
How to read this chart
- First-month price = the headline number you see on the provider’s landing page.
- Refill price (months 2–3) = what your card will be charged after the intro period.
- First-90-day total = Month 1 price + (Refill price × 2). Does not include labs or shipping unless stated as included.
- Same price every dose? = whether the provider’s pricing tiers up when your prescribed dose increases.
- Route = FDA-approved (brand-name drug, Novo Nordisk or Eli Lilly) or Compounded (licensed compounding pharmacy; not FDA-approved as a finished product).
| Provider | Plan | Route | First-month | Refill (mo 2–3) | First-90-day total | Same price every dose? | Membership separate? | HSA/FSA | BNPL | Cancel terms | Source / Last Verified |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-Approved Medications (Novo Nordisk / Eli Lilly) | |||||||||||
| Ro | Body membership only (no medication) | Membership | $39 | $149/mo (or $74/mo annual prepay) | $337 (membership only) | N/A | N/A — meds billed separately | Cash-pay membership; meds via insurance or cash | No | Cancel anytime | ro.co/weight-loss/pricing — |
| Ro | Wegovy® pill (lowest dose) + Body | FDA-approved | $39 + $149 = $188 | $149 (Body) + $149 (med) = $298/mo | $784 | No (med tiers by dose) | Yes — meds billed separately | Cash-pay; meds via insurance or cash | No | Cancel anytime | ro.co — |
| Ro | Wegovy® pen 0.25/0.5 mg (intro, limited time) | FDA-approved | $39 + $199 = $238 | $149 + $199–$349 (per Ro pricing page) | ~$934–$1,234 depending on dose | No (dose-tiered) | Yes | Same | No | Cancel anytime | ro.co — |
| Ro | Zepbound® KwikPen — starter titration (2.5 → 5 → 7.5 mg) | FDA-approved | $39 + $299 = $338 | $149 + $399, then $149 + $449 | $1,484 | No (dose-tiered: $299/$399/$449) | Yes | Same | No | Cancel anytime — note Ro’s 45-day refill condition for discounted higher-dose price | ro.co — |
| Ro | Foundayo™ (orforglipron, oral) — manufacturer offer | FDA-approved | $39 + $149 = $188 (low dose) | $149 + $149–$299 with manufacturer offer | $784–$1,084 | No (dose-tiered) | Yes | Same | No | Cancel anytime — manufacturer offer terms apply | ro.co/weight-loss/foundayo-cost — |
| Sesame | Wegovy® pill via Success by Sesame | FDA-approved | $99 + $149 = $248 | $99 + $149 = $248/mo | $744 | No (dose-tiered) | Yes — program fee + med | Cash-pay; HSA/FSA receipts accepted | No | Per terms | sesamecare.com — |
| Sesame | Wegovy® pen | FDA-approved | $99 + $199 = $298 (new patients, lower doses, first 2 months) | $99 + $349 (after first 2 months) = $448/mo | $1,194 | No (intro then $349 maintenance) | Yes | Same | No | Per terms | sesamecare.com — |
| Sesame | Zepbound® KwikPen | FDA-approved | $99 + $299 (2.5 mg) to $99 + $698 (10–15 mg) | Same tiers | $1,194 (low dose) to $2,391 (high dose) | No (dose-tiered: $299/$398/$499/$698) | Yes | Same | No | Per terms | sesamecare.com — |
| Sesame | Foundayo™ | FDA-approved | $99 + $149 (0.8 mg) to $99 + $349 (14.5–17.2 mg) | Same tiers | $744 (low dose) to $1,344 (high dose) | No (dose-tiered: $149/$199/$299/$349) | Yes | Same | No | Per terms | sesamecare.com — |
| Sesame + Costco | Wegovy® / Ozempic® at Costco Pharmacy (Costco members) | FDA-approved | $99 + $199 = $298 (new patient, low dose, first 2 mo) | $99 + $349 (Costco price, subject to change/location) = $448/mo | $1,194 | No (intro then maintenance) | Plus Costco membership | HSA/FSA | No | Per terms | sesamecare.com/blog — |
| Hims | Wegovy® pill (lowest dose) + Hims membership | FDA-approved | $39 + $149 = $188 | $149 (membership) + $149 (med) = $298/mo | $784 | No (med tiers by dose) | Yes — membership + med billed separately | Cash-pay | No | Per terms (prepaid plans nonrefundable) | hims.com/weight-loss — |
| Hers | Wegovy® pill (lowest dose) + Hers membership | FDA-approved | $39 + $149 = $188 | $149 + $149 = $298/mo | $784 | No (med tiers by dose) | Yes — membership + med separately | Cash-pay | No | Per terms | forhers.com — |
| Compounded Medications (Licensed Compounding Pharmacies — Not FDA-Approved as Finished Products) | |||||||||||
| MEDVi | Compounded semaglutide injection (monthly) | Compounded | $179 | $299 | $777 | No (refill jumps) | None | Cash-pay; HSA/FSA receipts | No | Cancel anytime | glp.medvi.org — |
| MEDVi | Compounded semaglutide injection (12-mo prepay) | Compounded | $179 effective | $179 effective | $537 (90-day equivalent) | No (annual locks rate) | None | Same | No | Annual commitment | glp.medvi.org — |
| MEDVi | Compounded tirzepatide injection | Compounded | $279 | [NEEDS CHECKOUT VERIFICATION] third-party reviews report $399–$499 | [NEEDS CHECKOUT VERIFICATION] | No | None | Same | No | Cancel anytime | glp.medvi.org / third-party reviews — |
| MEDVi | Compounded semaglutide oral tablet | Compounded | $249 | $369 | $987 | No | None | Same | No | Cancel anytime | glp.medvi.org — |
| Eden | Compounded semaglutide (monthly) | Compounded | $149 | $229 | $607 | ✓ Yes — flat at every dose | None | Yes | Yes | Cancel anytime via portal | tryeden.com — |
| Eden | Compounded semaglutide (3-month plan) | Compounded | $129 effective | $209 effective | $547 | ✓ Yes | None | Yes | Yes | 3-month commitment | tryeden.com — |
| Eden | Compounded tirzepatide (monthly) | Compounded | $249 | $329 | $907 | ✓ Yes | None | Yes | Yes | Cancel anytime | tryeden.com — |
| SHED | Compounded semaglutide injection | Compounded | $199–$299 [NEEDS CHECKOUT VERIFICATION] | Same | $597–$897 depending on plan | No | None for compounded | Yes | No | 2-month minimum, 72-hr notice | tryshed.com — |
| SHED | Compounded tirzepatide injection | Compounded | $299–$399 [NEEDS CHECKOUT VERIFICATION] | Same | $897–$1,197 | No | None | Yes | No | Same | tryshed.com — |
| SHED | GLP-1 lozenges (compounded oral) | Compounded | $199 | $199 | $597 | Mostly flat | None | Yes | No | Same | tryshed.com — |
| SHED | GLP-1 liquid drops (compounded oral) | Compounded | $229 | $229 | $687 | Mostly flat | None | Yes | No | Same | tryshed.com — |
| Gala GLP-1 | Compounded GLP-1, all-doses | Compounded | $179/mo (yearly subscription effective) or $199/mo (3-month plan) | Same as plan | $537–$597 over 90 days depending on plan | Mostly flat at $179 yearly tier | None disclosed | Cash-pay | No | Plan-length commitment for advertised rate | galaglp1.com — |
| Enhance MD | Core (compounded semaglutide) — month-to-month | Compounded | $49 (intro) | $212 (visible rate, all doses) | $473 | ✓ Yes — flat at every dose | Includes labs every 6 mo | Cash-pay | No | Cancel anytime | enhance.md — |
| Enhance MD | Advanced (compounded tirzepatide) | Compounded | $99 (intro) | $280 (visible rate, all doses) | $659 | ✓ Yes | Same | Same | No | Cancel anytime | enhance.md — |
| Enhance MD | Elite (sema + tirz combo) | Compounded | $189 (intro) | $322 (visible rate, all doses) | $833 | ✓ Yes | Same | Same | No | Cancel anytime | enhance.md — |
| Direct Meds | Sublingual semaglutide liquid | Compounded | $179.10 | $179.10 | $537 | Mostly flat | None disclosed | HSA/FSA accepted | No | Per terms | directmeds.com — |
| Direct Meds | Sublingual tirzepatide liquid | Compounded | $224.10 | $224.10 | $672 | Mostly flat | None | HSA/FSA accepted | No | Per terms | directmeds.com — |
| Direct Meds | Compounded semaglutide injection | Compounded | $297 | $297 | $891 | Mostly flat | None | HSA/FSA accepted | No | Per terms | directmeds.com — |
| Direct Meds | Compounded tirzepatide injection | Compounded | $399 | $399 | $1,197 | Mostly flat | None | HSA/FSA accepted | No | Per terms | directmeds.com — |
| Yucca Health | Compounded semaglutide (6-month plan, new patient) | Compounded | ~$146/mo effective | $146 effective | ~$438 (90-day eq.) | New-patient 6-mo offer | None | Yes | Klarna / Affirm / Afterpay | 6-month plan | tryyucca.com — |
| Yucca Health | Compounded tirzepatide (6-month plan, new patient) | Compounded | $258 effective | $258 effective | ~$774 (90-day eq.) | Same | None | Yes | BNPL | 6-month plan | tryyucca.com — |
| Yucca Health | Monthly tier (compounded) | Compounded | [NEEDS CHECKOUT VERIFICATION] | [NEEDS CHECKOUT VERIFICATION] | [NEEDS CHECKOUT VERIFICATION] | — | None | Yes | BNPL on 6-mo plans only | Cancel anytime | tryyucca.com — |
| Peter MD | Compounded GLP-1 + B12 (Level 1) | Compounded | $149 | ~$149/mo over ~10–12 weeks | ~$447 over the 10–12 week supply | Mostly flat at level | None | Cash-pay | No | Not available in AL, ID, AK, HI | getpetermd.com — |
Calculation rule: First-90-day total = (Month 1 price × 1) + (Refill price × 2) + any required labs/shipping/supplies not included in the plan. For brand-name FDA-approved medications where dose tiers up the price, we use a starter-dose scenario unless otherwise noted. Rows marked [NEEDS CHECKOUT VERIFICATION] indicate conflicting public pricing — verify at checkout before committing.
Run your real number — the GLP-1 90-Day Cost Estimator
Pick the medication, provider, plan length, and target maintenance dose and the estimator returns your month 1 cost, your month 6 cost, and your full year-1 total — including the refill jump and any dose-tier increases.
90-Day Cost Estimator
Our interactive estimator is in development. In the meantime, use the chart above to manually calculate your scenario: Month 1 price + (Refill price × 2) = your 90-day estimate.
Take our free matching quiz instead →Which row is you? Pick by situation, not by hype
The right GLP-1 provider depends on which constraint matters most: brand-name access, dose-stable pricing, format options, BNPL, premium clinical support, or insurance help. Each section below names a situation and points to the row that fits it.
If you want FDA-approved Wegovy®, Zepbound®, Ozempic®, Mounjaro®, or Foundayo™
Pick Ro first, Sesame second. Ro carries the broadest FDA-approved GLP-1 menu among consumer telehealth platforms — Wegovy® pen, Wegovy® pill, Zepbound® vials, Zepbound® KwikPen, Foundayo™ (orforglipron), and Ozempic®. Ro Body membership is $39 the first month, then as low as $74/month with annual prepay ($149/month on a regular monthly plan), and Ro matches LillyDirect®, NovoCare®, and TrumpRx pricing on the medication itself. Ro also runs a free GLP-1 Insurance Coverage Checker and includes an insurance concierge that handles prior-authorization paperwork.
A note on indications: Wegovy®, Zepbound®, and Foundayo™ are FDA-approved for chronic weight management. Ozempic® and Mounjaro® are FDA-approved for type 2 diabetes and may be prescribed only when a clinician determines you’re eligible.
Sesame Care is the cleanest secondary brand-name path. Success by Sesame starts at $99/month and Sesame carries Wegovy® pill, Wegovy® pen, Zepbound® KwikPen, Foundayo™, Ozempic®, Mounjaro®, and Saxenda®. Sesame’s distinguishing feature: Costco members can get Wegovy® and Ozempic® at $349/month at Costco Pharmacy with a Sesame prescription (subject to change/location), with new patients getting $199/month for the first two months on lower starter doses.
If you want the deepest cash-pay compounded menu
Pick MEDVi. MEDVi is one of the few telehealth platforms that carries compounded semaglutide and compounded tirzepatide in both weekly injectable and daily oral tablet form. Compounded semaglutide injection starts at $179 first month / $299 refill (or $179 effective on the 12-month prepay plan). MEDVi works with multiple licensed compounding pharmacies, is LegitScript-certified, and also offers FDA-approved options including Wegovy® and Zepbound® via a $99 membership-plus-medication pathway.
Honest limitation: MEDVi’s monthly refill price ($299 sema) is meaningfully higher than the first-month promo. If month-to-month flexibility at a flat price is your top priority, Eden is a better fit. But if you want the deepest menu — injection + tablet, sema + tirz, plus FDA-approved pathway — MEDVi is the only provider with all of it.
If your top priority is the price not jumping when your dose goes up
Pick Eden. Eden’s same-price-at-every-dose guarantee is the cleanest version of flat-rate pricing in compounded GLP-1 telehealth. Compounded semaglutide starts at $149 first month / $229 ongoing on the monthly plan, or $129 / $209 on the 3-month plan. No membership fees. Cancel anytime. HSA/FSA accepted at checkout. Free expedited shipping per Eden’s published terms. Enhance MD is the flat-rate runner-up if you also want metabolic labs included.
See Eden’s flat-rate plan →If you refuse to inject
Pick SHED for compounded oral. SHED has the widest compounded format menu in the chart — injection, drops, lozenges, liposomal tablet. Lozenges are $199/month; drops are $229/month, both mostly flat. SHED requires a 2-month minimum and 72-hour notice before the next billing cycle. For FDA-approved oral, your two paths are the Wegovy® pill ($149–$299/month through Ro or Sesame) and Foundayo™ — orforglipron, the first nonpeptide oral GLP-1 ever approved, launched April 2026 ($149–$299/month through Ro with manufacturer offer). If you want the cleanest regulatory profile, the FDA-approved oral path is the one to choose.
If you want metabolic lab work and a more clinical feel
Pick Enhance MD. Enhance MD includes metabolic lab testing every 6 months in every plan — that’s not standard in this category. Plans are tiered: Core (compounded semaglutide) at $49 first month / $212 ongoing; Advanced (compounded tirzepatide) at $99 / $280; Elite (semaglutide + tirzepatide combo) at $189 / $322. All three plans use flat pricing at every prescribed dose. Best fit: people who plateaued on semaglutide and want to escalate to tirzepatide, or anyone who wants lab-guided dose adjustment rather than purely asynchronous review.
Check eligibility with Enhance MD →If you want pay-over-time (Klarna, Affirm, Afterpay)
Pick Yucca Health. Yucca is one of the only telehealth GLP-1 providers in our chart that accepts Klarna, Afterpay, and Affirm — and their 6-month plan brings the effective monthly cost on compounded semaglutide down to $146/month, one of the lowest cash-pay numbers in the entire chart. Async provider review within 24 hours; no live video visit required. HSA/FSA accepted at checkout. Verify your specific plan’s terms at checkout since Yucca shares full pricing after eligibility is confirmed.
See Yucca’s BNPL plans →If you want a familiar mainstream consumer telehealth brand
Pick Hims (male-coded) or Hers (female-coded). Following the March 2026 Novo Nordisk partnership, both Hims and Hers now offer FDA-approved Wegovy® pen, Wegovy® pill, and Ozempic® at cash-pay prices starting at $149/month for the medication. The required Hims or Hers Weight Loss Membership is $39 first month, then $149/month — billed separately from medication. The cheapest 90-day total for the Wegovy® pill at the lowest dose is about $784 (membership + medication for three months). Hims/Hers prepaid plans are nonrefundable after purchase.
If you’re not sure which row fits you
Take the matching quiz. We ask 6 questions about budget, insurance, route preference, format, and state, and route you to the provider that fits.
Take the free 60-second GLP-1 matching quiz →Which GLP-1 provider has the lowest first-90-day cost?
In our verified chart, the lowest first-90-day total cash-pay cost is roughly $438 (Yucca Health 6-month plan, compounded semaglutide). The lowest FDA-approved 90-day total is roughly $744 through Sesame on the Wegovy® pill at the lowest dose. The cheapest first-month price is $39 — Ro Body membership, with the medication billed separately on top.
The 90-day cost rankings (verified April 2026)
Cheapest cash-pay compounded routes (starter-dose scenario):
- Yucca Health 6-month compounded semaglutide — ~$438
- bmiMD compounded semaglutide microdose — ~$447 (as low as)
- Enhance MD Core monthly with intro — $473
- MEDVi 12-month prepay (sema injection) — $537 (90-day eq.)
- Direct Meds sublingual semaglutide — $537
- Eden 3-month compounded semaglutide — $547
- Gala GLP-1 annual plan — $537 (90-day eq.)
- SHED lozenges — $597
- Eden monthly compounded semaglutide — $607
Cheapest FDA-approved routes (starter-dose scenario):
- Sesame Wegovy® pill at lowest dose — $744
- Ro Wegovy® pill at lowest dose — $784
- Hims/Hers Wegovy® pill at lowest dose — $784
A pricing reality from a 2025 JAMA Health Forum analysis: even with current cash-pay programs, brand-name GLP-1 medications still fall short of standard cost-effectiveness benchmarks at U.S. prices. Medicare drug-price negotiations expected to take effect in 2027 may bring further price reductions.
Why “cheapest” depends on which question you’re really asking
If your question is “which provider has the lowest sticker price for month one?” — Ro Body at $39 wins, but the medication is billed on top.
If your question is “which provider has the lowest 90-day total at a starter dose, paying cash?” — Yucca Health 6-month plan at $438 wins, but you’re committing to 6 months.
If your question is “which provider has the lowest ongoing cost without a long commitment?” — Eden monthly at $229/month is the lowest flat-rate compounded option that lets you cancel anytime.
Providers with the same price at every dose
Three providers in our verified chart use flat-rate pricing across all prescribed doses for compounded medication: Eden, Enhance MD, and Gala GLP-1 (yearly subscription effective rate). Most other providers — including MEDVi, SHED, Yucca, Hims/Hers, Sesame, and Ro’s Wegovy/Zepbound/Foundayo options — change pricing as your dose tiers up.
Most patients titrate up over 16–20 weeks. Semaglutide titration runs from 0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg over about 16 weeks. Tirzepatide runs from 2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg over about 20 weeks. If your provider tiers price with dose, your month-6 cost can be 30–60% higher than your month-1 cost.
Eden vs MEDVi monthly at semaglutide 2.4 mg, paying cash:
- Eden: $229/month flat ($149 first month) — month 6 still $229
- MEDVi monthly: $299/month at maintenance ($179 first month) — month 6 is $299
The $70/month difference is real. At low doses, MEDVi monthly is cheaper. At maintenance doses, Eden is cheaper. If you intend to escalate to maintenance, Eden’s flat rate often wins on year-1 totals.
The Price Trap Index — six pricing patterns that change your real cost
Six pricing patterns can make a provider’s headline price misleading: intro-month discount, annual-prepay effective rate, membership billed separately from medication, dose-tiered pricing, checkout-only price reveal, and cancellation cutoff timing. None of these is fraud — they’re standard telehealth billing practices. But you should know which patterns each provider uses before you enter your card.

Intro-month discount
Month one is cheap; month two is the real price. Used by Eden monthly, MEDVi monthly, Enhance MD, and most providers running first-month promos. Always verify the refill price before checkout.
Annual-prepay effective rate
The advertised "$74/month," "$179/month effective," or "$212/month" requires you to pay 6–12 months upfront. Used by Ro Body annual, MEDVi 12-month, Eden 3-month, Enhance MD annual plans, Gala GLP-1 annual.
Membership billed separately from medication
The provider charges a membership fee on top of the medication price. Used by Ro (Body membership $39/$149/$74-annual + medication separately), Hims and Hers, Sesame ($99/month + medication), and SHED's brand-name pathway.
Dose-tiered pricing
Your monthly price increases when your prescribed dose increases. Used by Ro's Wegovy® pen, Ro's Zepbound® KwikPen, Ro's Foundayo™, MEDVi monthly, SHED's compounded tirzepatide, Hims/Hers, Sesame's branded options.
Checkout-only price reveal
Public pricing pages don't show the full price until you complete intake. Yucca's monthly tier, MyStart Health, TrimRx, and parts of SHED fall into this pattern — marked [NEEDS CHECKOUT VERIFICATION] in the chart.
Cancellation cutoff timing
The provider requires advance notice (often 72 hours) before the next billing cycle. SHED uses this with a 2-month minimum and 72-hour notice. Hims and Hers prepaid plans are nonrefundable after purchase.
The “month 4 test”
Before you click any provider’s eligibility button, run this test: “What will I actually pay in month 4 at my expected dose?” If the provider’s pricing page doesn’t make that number obvious, contact their support before committing or use the chart above to calculate it yourself.
Compounded vs FDA-approved: what the price difference actually buys you
FDA-approved GLP-1 medications (Wegovy®, Zepbound®, Ozempic®, Mounjaro®, Foundayo™, Rybelsus®) are produced by Novo Nordisk or Eli Lilly under FDA oversight and have completed full clinical trials. Compounded GLP-1 medications are prepared by state- or federally-licensed pharmacies based on a clinician’s prescription and are not FDA-approved as finished products. The price difference reflects different products with different regulatory status — not a generic versus a brand.
Plain-language definitions
- FDA-approved finished drug
- A medication produced by a manufacturer (Novo Nordisk for semaglutide products, Eli Lilly for tirzepatide and orforglipron products) that has gone through full FDA review for safety, efficacy, and manufacturing quality, plus clinical trials. Brand-name GLP-1s in this category: Ozempic®, Wegovy® pen, Wegovy® pill, Rybelsus®, Mounjaro®, Zepbound® pen, Zepbound® vials, Zepbound® KwikPen, Foundayo™, and Saxenda®.
- 503A pharmacy
- A state-licensed compounding pharmacy that prepares medications for individual patients based on a prescription. State boards of pharmacy regulate them.
- 503B outsourcing facility
- A federally-registered compounding facility inspected by the FDA itself, with manufacturing standards closer to a drug manufacturer. 503B registration and inspection is not FDA approval of the finished compounded medication.
- Compounded medication
- A medication prepared by a compounding pharmacy. Not FDA-approved as a finished drug. Can be lawful when prescribed and dispensed under applicable 503A or 503B conditions.
What the FDA has actually said
The FDA has issued repeated cautions about compounded GLP-1 medications, including variability in dosing, source, salt-form, and fraudulent labeling across some products. The FDA has also issued warning letters to multiple telehealth companies in 2026 over false or misleading compounded GLP-1 marketing — including claims that compounded products are “the same as,” “generic versions of,” or “clinically proven like” the FDA-approved drugs. We do not make any of those claims on this page.
When FDA-approved is the cleaner path
- You want insurance to pay for at least part of it
- You want manufacturer pricing programs (LillyDirect®, NovoCare®, TrumpRx, Wegovy® Savings Offer)
- You want the manufacturing oversight of a finished FDA-approved drug
- You want the clearest regulatory profile
When compounded cash-pay is a reasonable path
- Insurance denied your GLP-1 and brand-name cash price is unaffordable
- You want a format not available in FDA-approved form (e.g., compounded injection at lower dose during titration)
- Your prescribing clinician determines a clinically significant difference is needed
- You want BNPL or HSA/FSA at checkout
Provider deep-dives: what each provider actually costs and includes
Ro
Punchline: Ro is the broadest FDA-approved GLP-1 provider in the chart, with the only free insurance coverage checker and prior-authorization concierge.
- Ro Body membership: $39 first month, then $149/month or as low as $74/month with annual prepay.
- Medication billed separately from the membership. Ro matches LillyDirect®, NovoCare®, and TrumpRx pricing on the medication.
- FDA-approved formulary: Wegovy® pen ($199/month for the first month on lower starter doses for a limited time, then $199–$349 thereafter); Wegovy® pill ($149–$299/month); Zepbound® vials; Zepbound® KwikPen ($299 at 2.5 mg, $399 at 5 mg, $449 at 7.5 mg+ with manufacturer offer); Foundayo™ orforglipron ($149–$299/month with manufacturer offer); Ozempic®.
- Insurance support: Free GLP-1 Insurance Coverage Checker; insurance concierge handles prior-authorization paperwork.
- Cancellation: Cancel anytime.
Best fit: anyone who wants FDA-approved medication, insurance help, prior-authorization support, or the broadest brand-name menu. Especially if you’re interested in Foundayo™, the new oral GLP-1 from Eli Lilly approved April 2026 and available through Ro from launch.
Check your GLP-1 coverage with Ro →MEDVi
Punchline: MEDVi is one of the strongest cash-pay options if you want the deepest compounded menu — both injectable and oral tablet, both semaglutide and tirzepatide.
- Compounded semaglutide injection: $179 first month / $299 ongoing, or $179 effective on the 12-month prepay plan.
- Compounded tirzepatide injection: $279 first month; refill rate varies — confirm at checkout because MEDVi’s tirzepatide refill price is one of the cells where third-party reports diverge from the provider’s pages.
- Compounded semaglutide oral tablet: $249 / $369.
- Pharmacy partners: MEDVi works with multiple licensed compounding pharmacies. Ask which pharmacy fills your specific prescription before paying.
- Other: LegitScript-certified; MEDVi self-reports more than 500,000 patients served; offers FDA-approved options including Wegovy® and Zepbound® via a $99 membership-plus-medication pathway.
- Cancellation: Cancel anytime month-to-month.
Honest limitation: MEDVi’s monthly refill price ($299 sema) is meaningfully higher than the first-month promo. If month-to-month flexibility at a flat price is your priority, Eden is a better fit. But MEDVi’s 12-month prepay plan locks you at $179 the whole year — one of the lowest compounded rates in the chart over 12 months.
See MEDVi’s current plans →Eden
Punchline: Eden’s same-price-at-every-dose guarantee is the cleanest version of flat-rate pricing in compounded GLP-1 telehealth.
- Compounded semaglutide: $149 first month / $229 ongoing on the monthly plan, or $129 / $209 on the 3-month plan.
- Compounded tirzepatide: $249 first month / $329 ongoing.
- Brand-name menu: Eden also carries Wegovy®, Zepbound®, Ozempic®, and Mounjaro® at brand-name pricing for patients who want FDA-approved through the same provider.
- Format options: compounded semaglutide injection, oral drops, GLP-1 gummies, plus brand-name injectable.
- HSA/FSA: accepted at checkout for visits and prescriptions.
- No membership fees, free expedited shipping (per Eden’s published terms).
- Cancellation: Cancel anytime through the patient portal.
Best fit: people who want flat-rate compounded pricing with HSA/FSA support, format flexibility, and cancel-anytime terms. The right choice if you’re planning to titrate to a higher dose and don’t want pricing surprises.
See Eden’s flat-rate plan →SHED
Punchline: SHED has the widest compounded format menu in the chart — injection, drops, lozenges, liposomal tablet — plus a brand-name pathway.
- Compounded semaglutide injection: $199–$299/month [verify at checkout — SHED’s public pages have shown different rates across product and landing pages]
- Compounded tirzepatide injection: $299–$399/month [verify at checkout]
- GLP-1 lozenges: $199/month (compounded oral)
- GLP-1 liquid drops: $229/month (compounded oral)
- Brand-name Wegovy® / Zepbound®: $99/month membership, medication priced separately at the pharmacy.
- Cancellation: 2-month minimum, 72-hour notice required before the next billing cycle.
Best fit: needle-averse people who want compounded oral options. Note: SHED’s published injection pricing has varied across pages, which is why those rows are flagged for checkout verification. Lozenge and drop pricing has been consistent.
See SHED’s needle-free options →Gala GLP-1
Punchline: Gala competes on annual all-in pricing with compounded GLP-1/GIP options.
- Yearly subscription effective: as low as $179/month all doses, no hidden fees per Gala’s homepage.
- 3-month plan: $199/month per Gala’s FAQ.
- Format: compounded semaglutide and tirzepatide; microdose options.
- Cancellation: plan-length commitment for the lowest advertised rate; final pricing determined at checkout.
Best fit: shoppers comfortable with annual subscription math who want a low all-in number. Verify the lump sum before assuming the monthly rate is month-to-month.
See Gala’s plans →Enhance MD
Punchline: Enhance MD is the cleanest option if you want included metabolic lab work and a more clinical feel.
- Core (compounded semaglutide): $49 first month / $212/month ongoing — flat at every dose
- Advanced (compounded tirzepatide): $99 first month / $280/month ongoing — flat at every dose
- Elite (semaglutide + tirzepatide combo): $189 first month / $322/month ongoing — flat at every dose
- Included: metabolic lab testing every 6 months, ongoing provider care.
Best fit: people who plateaued on semaglutide and want to escalate to tirzepatide or a combo, or anyone who wants lab-guided dose adjustment rather than purely asynchronous review.
Check eligibility with Enhance MD →Sesame Care
Punchline: Sesame is the cleanest secondary FDA-approved path, especially for Costco members.
- Success by Sesame: $99/month (or as low as $59/month with annual subscription).
- Brand-name menu: Wegovy® pill ($149/month at lowest dose, dose-tiered up to $349); Wegovy® pen ($199/month for new patients first 2 months, then $349/month); Zepbound® KwikPen (dose-tiered: $299 at 2.5 mg, $398 at 5 mg, $499 at 7.5 mg, $698 at 10–15 mg); Foundayo™; Ozempic®; Mounjaro®; Saxenda®.
- Costco partnership: Costco members get Wegovy® and Ozempic® at $349/month at Costco Pharmacy (subject to change/location); new patients get $199/month for the first two months on lower starter doses.
- Includes: lab work, video visits, messaging, ongoing provider support.
Best fit: patients who want FDA-approved medication with a broader formulary, especially if you’re a Costco member or want Saxenda® as an option.
See Sesame’s current brand-name pricing →Direct Meds
Punchline: Direct Meds is the cleanest oral/sublingual specialist if you specifically want sublingual tirzepatide or semaglutide at all-in pricing.
- Sublingual semaglutide liquid: $179.10/month
- Sublingual tirzepatide liquid: $224.10/month
- Compounded semaglutide injection: $297/month
- Compounded tirzepatide injection: $399/month
- HSA/FSA: accepted per Direct Meds’ published terms.
- Included: shipping, nurse support, follow-ups in the all-in price.
Note: Direct Meds’ homepage lists plans starting at $249/month for sublingual semaglutide while their product listing shows $179.10/month — confirm your specific plan at checkout. Compounded oral formats are not FDA-approved finished drugs; verify the formulation, source, and pharmacy with your prescriber.
Compare Direct Meds pricing →Yucca Health
Punchline: Yucca is the BNPL specialist with one of the lowest effective monthly numbers in the chart.
- Compounded semaglutide (new patient, 6-month plan): $146/month effective.
- Compounded tirzepatide (new patient, 6-month plan): $258/month effective.
- Monthly tier: Yucca shares full pricing after intake once eligibility is confirmed; verify your specific plan’s monthly-tier price at checkout.
- BNPL: Klarna, Affirm, and Afterpay accepted on 6-month plans.
- Provider review: asynchronous within 24 hours; no live visit required.
- Onboarding: scheduled call with your provider after approval.
Best fit: value-first shoppers who want BNPL, async review, and the lowest effective monthly cost on compounded semaglutide.
See Yucca’s BNPL plans →Hims and Hers
Punchline: Hims and Hers are the most familiar consumer telehealth brands offering FDA-approved Novo Nordisk and Eli Lilly GLP-1s, with broader formularies after the March 2026 partnership.
- Membership required: Hims or Hers Weight Loss Membership at $39 first month, then $149/month, billed separately from medication.
- Medication: Wegovy® pill, Wegovy® pen, Zepbound® vials, Zepbound® KwikPen, Foundayo™, Ozempic®, Mounjaro®. Pricing starts at $149/month for the lowest-dose Wegovy® pill, with dose-tiered pricing at higher doses. Lowest 90-day total at the starter dose: about $784.
- Indication note: Wegovy®, Zepbound®, and Foundayo™ are FDA-approved for weight loss. Ozempic® and Mounjaro® are FDA-approved for type 2 diabetes and may be prescribed only when a clinician determines you’re eligible.
- Hims = male-coded mainstream brand. Hers = female-coded mainstream brand. Same FDA-approved menu structure.
- Cancellation: prepaid plans are nonrefundable after purchase.
Best fit: people who want a familiar consumer brand and FDA-approved medication, and who are okay with the membership-plus-medication structure. Skip if you want compounded — Hims/Hers have largely deprioritized compounded GLP-1 advertising on their platforms after the deal.
Secondary providers worth knowing about
These are legitimate options for narrower fits. Verify pricing on their site before committing.
- Peter MD — male-skewed optimization with GLP-1 + B12. Level 1 plan at $149/month, $447 over the 10–12 week supply. Not available in AL, ID, AK, or HI. Good fit if you also want TRT-adjacent or men’s optimization access.
- MyStart Health — all-inclusive price-lock positioning with HSA/FSA reimbursement language. Around $299/month claim. [NEEDS CHECKOUT VERIFICATION] before relying on price-lock.
- TrimRx — compounded GLP-1 starter advertised at $199/month, with TrimRx’s terms page showing a $299 package — confirm your specific plan at checkout. Verify cancellation terms before committing.
- Willow — compounded semaglutide tablets at $299/month subscription / $399 one-time. HSA/FSA eligible, free 2-day shipping. Niche tablet/HSA-FSA fit.
- bmiMD — compounded semaglutide as low as $149/month and tirzepatide as low as $249/month. HSA/FSA eligible. Niche option for microdose protocols.
Can I use insurance, HSA, or FSA for online GLP-1 providers?
Insurance is most useful for FDA-approved brand-name medications through providers like Ro and Sesame, where prior-authorization support is built in. Most cash-pay compounded providers don’t bill insurance directly; some — Eden, SHED, Yucca Health, Direct Meds, Willow, and bmiMD — accept HSA/FSA at checkout, while others issue itemized receipts you can submit to your HSA/FSA administrator for reimbursement. HSA/FSA eligibility for GLP-1s for weight loss often requires a Letter of Medical Necessity from your prescribing clinician.
Best route for insurance help
Ro. Ro’s free GLP-1 Insurance Coverage Checker tells you whether your plan covers Wegovy®, Zepbound®, Ozempic®, or Foundayo™ before you commit. Ro’s insurance concierge handles prior-authorization paperwork. If your insurance covers a GLP-1, this is the cleanest way to find out without surprises.
Run Ro’s free insurance coverage checker →HSA/FSA at checkout
In our verified chart, the providers that accept HSA/FSA cards directly at checkout are Eden, SHED, Yucca Health, Direct Meds, Willow, and bmiMD. MEDVi, Enhance MD, Gala, and Peter MD operate cash-pay; you can submit an itemized receipt to your HSA/FSA administrator for reimbursement consideration. Verify with your specific administrator first — FSA reimbursement for GLP-1s for weight loss often requires a Letter of Medical Necessity that your prescribing clinician can write.
What’s typically covered vs not
- GLP-1s prescribed for type 2 diabetes (Ozempic®, Mounjaro®) are more commonly covered by insurance than GLP-1s prescribed for weight loss.
- GLP-1s for weight loss (Wegovy®, Zepbound®, Foundayo™, Saxenda®) are inconsistently covered. Check your specific plan’s formulary or use Ro’s free checker.
- Compounded GLP-1s are generally not covered by insurance.
- Medicare: the Medicare GLP-1 Bridge runs July 1, 2026 through December 31, 2027 and makes eligible GLP-1 drugs available to eligible Part D beneficiaries. CMS currently lists Foundayo™, Wegovy® injection and tablets, and Zepbound® KwikPen as eligible drugs in the Bridge program. Verify your specific eligibility on Medicare.gov.
Real customer experiences (process, not medical results)
The testimonials below are sourced from public, provider-hosted review pages and reflect individual experience with the signup, support, and delivery process. They are not evidence of medical safety, efficacy, or typical weight-loss results.
“I just had my first shot yesterday. It was a quick and smooth process from the questionnaire to the shipment of my treatment. I was eligible in 24 hours.”
“Initially, I wasn’t certain of how personal this process would feel, expecting to become an anonymous case number. I have been completely and totally proven otherwise.”
“From that point forward I’ve had no issues and the process is pretty easy and fast. I’ve had no issues with the company and the medication is working for me.”
Disclosure: These quotes describe individual user experience with sign-up, communication, and delivery. They are not testimony to medical outcomes, and we do not present them as evidence of typical weight loss. GLP-1 prescribing decisions are made by licensed clinicians based on your individual health profile.
How we verified this GLP-1 provider cost comparison chart
We open each provider’s published pricing page, capture the price cell with the date, and store the source URL. Where a provider hides full pricing behind intake, where the public pages show conflicting numbers, or where we relied on a third-party review, we mark the row [NEEDS CHECKOUT VERIFICATION] rather than guess. We verify quarterly and update the Last Verified date when any cell changes.
What we checked on
- Provider-published pricing pages for every row in the chart.
- First-month price, refill price, plan-length variations, dose-pricing rules, and cancellation terms as published by the provider.
- Manufacturer pricing for the FDA-approved medications (LillyDirect®, NovoCare®, TrumpRx) where Ro and Sesame match those prices.
- FDA pages for compounding policy, warning letters to telehealth companies, and consumer cautions.
- CMS pages for the Medicare GLP-1 Bridge program.
- Public review and complaint sources for consumer-friction signals (cancellation, billing, support quality) — used as objection inputs for the segmentation, not as medical evidence.
What we did not claim
- We did not call any compounded GLP-1 “the same as” or a “generic version of” a brand-name FDA-approved drug.
- We did not claim compounded products are FDA-approved.
- We did not present testimonials as proof of medical outcomes or typical results.
- We did not invent star ratings or “medically reviewed by” credentials.
- We did not assign schema to content that isn’t visibly published on the page.
- We did not call third-party review pricing “verified” — only provider-published pricing and direct checkout confirmations get the verified label.
Price Clarity Score (0–10)
We score each provider on how transparently they publish what they charge. Higher score = the published price is the price you actually pay. Components: public starting price visible (1 pt), ongoing/refill price visible without intake (2 pts), membership clearly stated (2 pts), fees itemized (1 pt), dose-pricing rules stated (1 pt), cancellation terms visible (1 pt), FDA vs compounded route clearly separated (1 pt), no material unresolved verification flag (1 pt). The Score rewards transparency, not the lowest price. A provider can be expensive and score 10/10.
How readers can report corrections
Provider pricing changes constantly. If you find a cell in our chart that’s out of date, send a screenshot of the current pricing page to [email protected] and we’ll re-verify and update the chart with a new Last Verified date.
Red flags to avoid when buying a GLP-1 online
Avoid any GLP-1 seller that doesn’t require clinician review, sells “research use only” peptides, hides its pharmacy or sourcing, guarantees specific weight-loss outcomes, or markets compounded products as FDA-approved or as generics of brand-name drugs.
Green flags
- A licensed clinician reviews your intake before any prescription.
- Prescription-only — no GLP-1 without a prescription.
- The medication route (compounded vs FDA-approved) is clearly labeled.
- The compounding pharmacy or manufacturer is disclosed on request.
- Pricing is visible before checkout.
- Cancellation, refund, and non-approval refund terms are published.
- Outcome claims are conservative — no guarantees of “X pounds in Y weeks.”
Red flags
- “No prescription required.”
- “Research use only” or “not for human consumption” peptides being sold to consumers.
- Guaranteed weight-loss results.
- No clinician review before shipping.
- No pharmacy or sourcing disclosure when asked.
- Star ratings without real reviews.
- Marketing language calling compounded products “generic Wegovy®” / “generic Ozempic®” / “FDA-approved compounded.”
- Prices wildly below market from outside the FDA-regulated U.S. supply chain.
Frequently asked questions
What is the cheapest GLP-1 provider per month in 2026?
The cheapest verified 90-day total cash-pay cost in our chart is roughly $438 — Yucca Health compounded semaglutide on a 6-month plan at about $146/month effective. The lowest FDA-approved 90-day total is roughly $744 through Sesame Care on the Wegovy® pill at the lowest dose ($99 program + $149 medication × 3 months). The lowest advertised first-month headline price is $39 — Ro Body membership, with medication billed separately on top.
Which GLP-1 provider has the same price at every dose?
Three providers in our verified chart use flat-rate compounded pricing across all prescribed doses: Eden ($229/month for compounded semaglutide on the monthly plan, $209 on the 3-month plan), Enhance MD (Core $212/month, Advanced $280/month, Elite $322/month — all flat at every dose), and Gala GLP-1 on the yearly subscription tier ($179 effective).
How much does compounded semaglutide cost per month?
In our verified chart, compounded semaglutide ranges from $146/month (Yucca Health 6-month plan, effective rate) to $369/month (MEDVi compounded semaglutide oral tablet, refill price). First-month promotional pricing typically runs $129–$199. Most flat-rate compounded options sit between $209 and $249/month at typical maintenance doses.
How much does Wegovy® cost without insurance?
Wegovy® has a list price of $1,349.02/month. Through Ro and Sesame Care, the Wegovy® pen is $199/month for new patients on the lower starter doses (limited time / first 2 months on Sesame), then up to $349/month at typical maintenance doses. The Wegovy® pill is $149–$299/month depending on dose. With a commercial insurance Wegovy® Savings Offer, eligible patients can pay as little as $0–$25/month for a 28-day supply.
Can I use HSA or FSA for online GLP-1 providers?
Eden, SHED, Yucca Health, Direct Meds, Willow, and bmiMD accept HSA/FSA cards at checkout. MEDVi, Enhance MD, Gala, and Peter MD operate cash-pay but issue itemized receipts you can submit to your HSA/FSA administrator. FSA reimbursement for GLP-1s for weight loss often requires a Letter of Medical Necessity from your prescribing clinician.
Are compounded GLP-1 medications safe?
Compounded GLP-1 medications are not FDA-approved as finished products and have not been reviewed by the FDA for safety, effectiveness, or quality. The FDA has cautioned about variability in some compounded GLP-1 products, including dosing, source, and label concerns. Compounded medications can be lawfully prescribed when a clinician determines a clinically significant difference is needed for an identified patient under applicable 503A or 503B conditions. If you choose a compounded provider, ask which pharmacy fills your prescription and request licensed-pharmacy details.
Are compounded semaglutide and tirzepatide generic versions of Wegovy®, Ozempic®, or Zepbound®?
No. Compounded GLP-1s are not generic versions of any FDA-approved drug. Compounded medications are prepared by compounding pharmacies under a clinician's prescription; brand-name GLP-1 drugs are produced by Novo Nordisk or Eli Lilly under FDA oversight. The FDA has specifically warned against marketing language that calls compounded products "generic" or "the same as" the FDA-approved drugs.
Which GLP-1 provider has the broadest FDA-approved formulary?
Ro carries the broadest FDA-approved GLP-1 formulary among the providers in our chart — Wegovy® pen, Wegovy® pill, Zepbound® vials, Zepbound® KwikPen, Foundayo™ (orforglipron), and Ozempic® — and matches LillyDirect®, NovoCare®, and TrumpRx pricing on the medication. Sesame Care is a close second with a similarly broad menu including Wegovy®, Zepbound®, Ozempic®, Mounjaro®, Foundayo™, and Saxenda®.
Do any GLP-1 providers offer BNPL (Klarna, Afterpay, Affirm)?
Yucca Health accepts Klarna, Afterpay, and Affirm on 6-month plans — that's the cleanest BNPL option in our chart. Other providers in the chart did not have BNPL at the time of our April 28, 2026 verification.
Can I cancel a GLP-1 telehealth plan anytime?
Eden, MEDVi monthly, Enhance MD monthly, and Ro Body allow cancellation anytime through the patient portal. SHED requires a 2-month minimum and 72-hour notice. Hims and Hers prepaid plans are nonrefundable after purchase. Annual prepay plans (MEDVi 12-month, Eden 3-month, Gala annual, Enhance MD annual) lock you into the term for the lower effective rate.
What is Foundayo™ and how is it priced?
Foundayo™ is the brand name for orforglipron, a once-daily oral GLP-1 from Eli Lilly approved by the FDA in April 2026 for weight loss. It's the first nonpeptide, small-molecule oral GLP-1 ever approved. Through Ro, Foundayo™ is priced at $149–$299/month with manufacturer offer depending on dose, plus the Ro Body membership ($39 first month, then $149/month or as low as $74/month with annual prepay). Sesame Care also carries Foundayo™ at $149–$349/month depending on dose.
What if my provider doesn't approve me for a GLP-1 prescription?
Most providers refund the program fee or first-month payment if you're not approved, but policies vary — confirm the non-approval refund policy on the provider's pricing or terms page before paying. Yucca Health says you're only charged once approved. Always verify before entering your card.
How often is this chart updated?
Quarterly for the full chart (next review: July 28, 2026), with monthly spot-checks on any provider that announces a pricing change. The Last Verified date on each row updates when we re-confirm or change the cell.
Still not sure which GLP-1 program is right for you?
If you’ve read the chart and the segmentation and you’re still close between two or three providers, take the matching quiz. We ask 6 questions about budget, insurance status, route preference, format, and state, and route you to the provider that fits your answers — with the math from the chart attached.
Take our free 60-second GLP-1 matching quiz →Sources and verification
All pricing verified from each provider’s published pricing page. Direct sources:
- Ro: ro.co/weight-loss/pricing, ro.co/weight-loss/foundayo-cost, ro.co/weight-loss/glp1-insurance-checker
- Sesame Care: sesamecare.com, sesamecare.com/blog/costco-half-price-ozempic-wegovy
- MEDVi: glp.medvi.org
- Eden: tryeden.com/treatment/glp-1-treatments
- SHED (ShedRx): tryshed.com
- Gala GLP-1: galaglp1.com
- Enhance MD: enhance.md
- Direct Meds: directmeds.com
- Yucca Health: tryyucca.com
- Hims & Hers: hims.com/weight-loss, forhers.com
- Peter MD: getpetermd.com/glp1-b12
- FDA compounding and consumer information: fda.gov
- CMS Medicare GLP-1 Bridge: cms.gov
About this page
This page is published by the Weight Loss Provider Guide research team — an independent comparison resource for GLP-1 telehealth providers. We do not provide medical advice. We do not prescribe medications. We do not have clinical relationships with patients.
Some links on this page are affiliate links. When you click an affiliate link and sign up for a provider, we may earn a commission. Affiliate relationships do not change our editorial conclusions, chart data, or provider limitations. We disclose every affiliate relationship on this page and in our site-wide advertising disclosure.
This page is updated quarterly for the full chart and monthly for spot-checks on pricing changes. Next scheduled review: